The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
it's more complicated because that's just showing you the total epa DHA and in some patients you really want to see that DHEA preferenced preferentially higher versus the epa and it does depend quite a bit on what which axis were most worried about whether it be the neurodegenerative axis in which case the DHEA might be a little more important or the atherosclerosis in which the EPA might be more important
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.